Effects of metformin on parasitological, pathological changes in the brain and liver and immunological aspects during visceral toxocariasis in mice
Open Access
- 24 October 2023
- journal article
- research article
- Published by Springer Nature in Parasitology Research
- Vol. 122 (12) , 3213-3231
Abstract
There are currently insufficient anthelmintic medications available for the treatment of toxocariasis. For instance, Albendazole (ABZ) is the preferred medication, but its effectiveness against tissue-dwelling parasites is limited. In addition, Metformin (MTF) is a widely used oral antidiabetic medication that is considered to be safe for treatment. This study aimed to investigate any potential effects of MTF, alone or in combination with ABZ, on mice infections caused by Toxocara canis (T. canis). The efficacy of the treatment was assessed in the acute and chronic phases of the infection by larval recovery and histopathological, immunohistochemical, and biochemical studies. The results showed that combined therapy significantly reduced larval counts in the liver, brain, and muscles and ameliorated hepatic and brain pathology. It reduced oxidative stress and TGF-β mRNA expression and increased FGF21 levels in the liver. It decreased TNF-α levels and MMP-9 expression in the brain. In addition, it increased serum levels of IL-12 and IFN-γ and decreased serum levels of IL-4 and IL-10. In the acute and chronic phases of the infection, the combined treatment was more effective than ABZ alone. In conclusion, this study highlights the potential role of MTF as an adjuvant in the treatment of experimental T. canis infection when administered with ABZ.Keywords
Funding Information
- Tanta University
This publication has 89 references indexed in Scilit:
- MMP-9 Inhibition: a Therapeutic Strategy in Ischemic StrokeMolecular Neurobiology, 2013
- Toxocara canis: Molecular basis of immune recognition and evasionVeterinary Parasitology, 2013
- Signal Transducer and Activator of Transcription Factor 6 Signaling Contributes to Control Host Lung Pathology but Favors Susceptibility againstToxocara canisInfectionBioMed Research International, 2013
- Metformin Stimulates FGF21 Expression in Primary HepatocytesExperimental Diabetes Research, 2012
- Emerging Zoonoses in the Southern United States: Toxocariasis, Bovine Tuberculosis and Southern Tick-Associated Rash IllnessThe American Journal of the Medical Sciences, 2010
- Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathwayBiochemical and Biophysical Research Communications, 2010
- Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canisin miceBMC Infectious Diseases, 2008
- A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese populationBMC Infectious Diseases, 2008
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006
- Toxocara canis infection induces antigen-specific IL-10 and IFNγ production in pregnant dogs and their puppiesVeterinary Immunology and Immunopathology, 2005